Crossject (ALCJ)

Paris

Currency in EUR

ALCJ Pro Research

1.992

+0.012(+0.61%)

Closed·27/03

Fair Value

Unlock Value

Day's Range

1.970

2.000

52 wk Range

0.720

2.695

Crossject (ALCJ) Income Statement & Profits

Assess the Crossject Income Statement (earnings report), showing the company's financial performance from operating and non operating activities such as revenue, expenses and income. Check assets and liabilities, diluted earnings per share (EPS), and net income after taxes for the last 4 periods (either quarterly or annually).

Investors who need greater depth or who want to customise how data is presented to fit their own investment styles are able to do so via their very own InvestingPro account.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

6.48

7.06

3.87

4.12

15.02

Total Revenues Growth

aa.aa

+33.77%

+9%

-45.18%

+6.28%

+265.03%

Cost Of Revenues

aa.aa

6.69

8.26

9.87

12.03

12.14

Gross Profit

aa.aa

-0.21

-1.2

-6

-7.92

2.88

Gross Profit Growth

aa.aa

+40.23%

-485.85%

-399.75%

-31.91%

+136.36%

Gross Profit Margin %

aa.aa

-3.16%

-17%

-155.01%

-192.39%

19.17%

Other Operating Expenses, Total

aa.aa

11.62

12.09

5.8

5.05

14.49

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+12.48%	+4.04%	-52.02%	-13%	+187.12%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	6.18	7.43	7.71	7.8	7.78
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.95	-0.6	-6.42	-7.6	1.82

Operating Income

aa.aa

-11.82

-13.29

-11.8

-12.96

-11.61

Operating Income Growth

aa.aa

-10.79%

-12.39%

+11.19%

-9.84%

+10.46%

EBIT Margin %

aa.aa

-182.45%

-188.14%

-304.78%

-314.99%

-77.27%

Net Interest Expenses

aa.aa

-0.33

-0.18

-0.74

-1.08

Net Interest Expenses Growth

aa.aa

-7.49%

+44.24%

-300.54%

-46%

Interest Expense, Total

aa.aa

-0.33

-0.18

-0.74

-1.08

Interest And Investment Income

aa.aa

Other Non Operating Expenses, Total

aa.aa

-0.56

-0.13

-0.06

-0.59

-1.58

EBT, Excl. Unusual Items

aa.aa

-12.72

-13.6

-12.6

-14.62

-13.18

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

0.08

-0.2

0.79

-1.23

EBT, Incl. Unusual Items

aa.aa

-12.62

-13.38

-11.51

-15.62

-13.18

EBT, Incl. Unusual Items Growth

aa.aa

-9.87%

-5.98%

+13.99%

-35.75%

+15.6%

EBT, Incl. Unusual Items Margin

aa.aa

-194.81%

-189.42%

-297.18%

-379.61%

-87.77%

Income Tax Expense

aa.aa

-1.82

-2.22

-2.87

-2.83

-2.82

Net Income to Company

aa.aa

-10.81

-11.16

-8.64

-12.8

-10.37

Minority Interest

aa.aa

Net Income

aa.aa

-10.81

-11.16

-8.64

-12.8

-10.37

Net Income Growth

aa.aa

-9.77%

-3.25%

+22.56%

-48.09%

+18.98%

Net Income Margin %

aa.aa

-166.76%

-157.96%

-223.14%

-310.94%

-69.02%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-10.81

-11.16

-8.64

-12.8

-10.37

Basic EPS - Continuing Operations

aa.aa

-0.41

-0.31

-0.24

-0.28

Basic EPS - Continuing Operations Growth

aa.aa

-0.72%

+26.05%

+23.41%

-19.55%

Diluted EPS - Continuing Operations

aa.aa

-0.41

-0.31

-0.24

-0.28

Diluted EPS - Continuing Operations Growth

aa.aa

-0.72%

+26.05%

+23.41%

-19.55%

Basic Weighted Average Shares Outstanding

aa.aa

26.04

36.36

36.76

45.54

Diluted Weighted Average Shares Outstanding

aa.aa

26.04

36.36

36.76

45.54

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-7.33

-8.03

-7.3

-12.04

-5.91

EBITDA Growth

aa.aa

-9.07%

-9.44%

+9.07%

-64.94%

+50.94%

EBITDA Margin %

aa.aa

-113.16%

-113.62%

-188.46%

-292.49%

-39.31%

EBIT

aa.aa

-11.82

-13.29

-11.8

-12.96

-11.61

* In Millions of EUR (except for per share items)

FAQ

What was Crossject’s revenue at year end?

At the end of the last reported fiscal year, Crossject (ALCJ) recorded total revenue of 15.021 million EUR.

How much revenue did Crossject report in the most recent quarter?

In its most recent quarterly earnings report, Crossject posted revenue of 1.540 million EUR.

What was Crossject’s net income for the year?

For the full year, Crossject reported net income of -10.367 million EUR.

How much net income did Crossject post in the last quarter?

In the most recent quarter, Crossject (ALCJ) posted net income of -4.869 million EUR.

What was Crossject’s gross profit for the year?

Gross profit for the year was reported at 2.879 million EUR.

How much gross profit did Crossject generate last quarter?

Crossject recorded gross profit of -4.498 million EUR in its latest quarterly report.

What was Crossject’s annual operating income?

For the full year, Crossject (ALCJ) reported operating income of -11.606 million EUR.

What was Crossject’s operating income last quarter?

Quarterly operating income was -5.139 million EUR.

What was Crossject’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -4.290 million EUR.

What was the quarter-over-quarter change in EBITDA for Crossject?

EBITDA changed by 20.393% million EUR compared to the last quarter.r.

How did Crossject’s revenue change compared to the previous quarter?

Revenue changed by -39.203% million EUR compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Crossject?

In the latest quarter, gross profit changed by -8.307% million EUR from the previous quarter.

FTSE 100

9,967.35

-4.82

-0.05%

DAX

22,300.75

-312.22

-1.38%

Euro Stoxx 50

5,505.80

-60.13

-1.08%

S&P 500

6,368.85

-108.31

-1.67%

Nikkei 225

53,373.07

-230.58

-0.43%

Dow Jones

45,166.64

-793.47

-1.73%

FTSE 100 Futures

9,976.50

-1.0

-0.01%

Market Movers

Name	Last	Chg. %	Vol.
Barclays	382.20	-0.84%	120.50M
BP	584.10	+0.17%	90.48M
NatWest Group	539.80	+0.90%	77.05M
Rolls-Royce Holdings	1,108.50	-3.61%	32.26M
National Grid	1,236.50	-0.04%	29.03M
British American Tobacco	4,351.0	+0.51%	6.54M
AstraZeneca	14,302.0	+3.41%	2.66M

Name	Last	Chg. %	Vol.
Tap Global Group	1.75	+40.00%	7.89M
ENGAGE XR Holdings	0.22	+28.57%	7.58M
Gem Resources	0.25	+25.00%	2.29M
Mobilityone	9.50	+22.58%	4.98M
Marley Spoon	0.22	+21.62%	137.00
Everyman Me	31.00	+21.57%	803.07K
Synthomer	36.00	+20.60%	4.28M

Name	Last	Chg. %	Vol.
Centaur	13.50	-43.75%	1.41M
Burford	339.00	-42.35%	3.14M
Switch Metals	11.00	-24.14%	1.25M
GSTechnologies	0.1900	-24.00%	78.14M
CTS Eventim AG	49.83	-22.56%	300.73K
Insight Molecular Diagnostics	3.37	-21.26%	1.23K
Trellus Health	0.23	-18.18%	12.51M

Trending Stocks

Name	Last	Chg. %	Vol.
BP	584.10	+0.17%	90.48M
Rolls-Royce Holdings	1,108.50	-3.61%	32.26M
AstraZeneca	14,302.0	+3.41%	2.66M
Xtract Resources	0.825	-5.71%	7.75M
Legal & General	240.60	-0.37%	17.15M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa Aa Aaaa Aaaaaa	1,243.00	+65.01%	2,051.07
Aaaaaaaaaaaaa	274.90	+43.58%	394.70
Aaaaaaaaaa Aaa	255.70	+38.92%	355.22
Aa Aaaa Aaa Aa	1,402.5	+37.83%	1,933.1
Aaaaaaa	2,049.00	+33.20%	2,729.27
Aaaaaaa Aaaaaaaa	584.10	+29.38%	755.71
Aaa Aaaaaa	811.20	+27.58%	1,034.93

Name	Last	Upside	Fair Value
Aa Aa Aaaa Aaaaaa	1,243.00	+65.01%	2,051.07
Aaaaaaaaaaaaa	274.90	+43.58%	394.70
Aaaaaaaaaa Aaa	255.70	+38.92%	355.22
Aa Aaaa Aaa Aa	1,402.5	+37.83%	1,933.1
Aaaaaaa	2,049.00	+33.20%	2,729.27
Aaaaaaa Aaaaaaaa	584.10	+29.38%	755.71
Aaa Aaaaaa	811.20	+27.58%	1,034.93

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Crossject (ALCJ)

Crossject (ALCJ) Income Statement & Profits

FAQ

What was Crossject’s revenue at year end?

How much revenue did Crossject report in the most recent quarter?

What was Crossject’s net income for the year?

How much net income did Crossject post in the last quarter?

What was Crossject’s gross profit for the year?

How much gross profit did Crossject generate last quarter?

What was Crossject’s annual operating income?

What was Crossject’s operating income last quarter?

What was Crossject’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Crossject?

How did Crossject’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Crossject?

Trending Stocks